Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

UCSF at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

UCSF brings 33 presentations to ASH 2026 in New Orleans. Its program centres on CAR T-cell therapy and bispecific antibodies in myeloma and lymphoma. It covers droplet PCR for tracking residual leukemia and cell-free DNA for lymphoma diagnosis in sub-Saharan Africa.

OrganizationASH 2026 Attendance
UCSF
San Francisco, CA
Universities & research institutes
University of California's health sciences campus in San Francisco, focused on medicine, biomedical research and graduate health education.
Symposium
Fri Dec 11
11:00am–2:00pm
A Case-Based Exploration of CAR T-Cell Therapy in Multiple Myeloma – Where We Are, Where We’re Going
Real patient cases showing how experts use approved and investigational CAR-T therapies in multiple myeloma now, and where the treatment is heading.
Myeloma · Cell & gene
Symposium
Fri Dec 11
3:00pm–6:00pm
Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era
Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing.
Leukemias
Symposium
Fri Dec 11
7:00pm–10:00pm
Advancing the DLBCL Paradigm: Sequencing Bispecifics in Optimizing Patient Care
Where bispecific antibodies fit in diffuse large B-cell lymphoma, weighed against CAR-T by patient fitness, access, and T-cell health.
Lymphoma · New drugs
Talk
Sun Dec 13
9:30am–10:45am
Promoting the Peacekeepers: Treg Adoptive Therapies to Re-Establish Tolerance
Regulatory T cells redirected with chimeric antigen receptors to restore immune tolerance in rheumatoid arthritis, from lab studies to clinical findings.
Cell & gene
Talk
Mon Dec 14
4:30pm–5:45pm
Bispecific Antibodies OR CAR-T in Early Relapse for Multiple Myeloma
Comparing CAR-T cells with off-the-shelf bispecific antibodies for early-relapse myeloma, weighing trial evidence, risks, and the best treatment order.
Myeloma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UCSF

Tell us what you sell and we’ll find the people at UCSF most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction